New patent for Alcon Labs drug EYSUVIS – DrugPatentWatch
Annual Drug Patent Expiration for EYSUVIS
Eysuvis is a drug marketed by Alcon Labs Inc and included in one NDA. It is available from a single supplier. There are thirteen patents protecting this drug.
Trends in drug prices EYSUVIS.
This drug has eighty patent family members in twelve countries.
The generic ingredient in EYSUVIS is loteprednol etabonate. One registered supplier for this compound. Additional details are available on the loteprednol etabonate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Alcon Labs EYSUVIS
